Research Center Biomedica En Red Of Diabetes fermedades Metabolicas Asoc

Barcelona, Spain

Research Center Biomedica En Red Of Diabetes fermedades Metabolicas Asoc

Barcelona, Spain

Time filter

Source Type

Oliveira J.M.,Institute dInvestigations Biomediques August Pi i Sunyer | Oliveira J.M.,Research Center Biomedica En Red Of Diabetes fermedades Metabolicas Asoc | Rebuffat S.A.,Institute dInvestigations Biomediques August Pi i Sunyer | Rebuffat S.A.,Research Center Biomedica En Red Of Diabetes fermedades Metabolicas Asoc | And 15 more authors.
American Journal of Physiology - Endocrinology and Metabolism | Year: 2014

Pancreatic β-cells play a central role in type 2 diabetes (T2D) development, which is characterized by the progressive decline of the functional β-cell mass that is associated mainly with increased β-cell apoptosis. Thus, understanding how to enhance survival of β-cells is key for the management of T2D. The insulin receptor substrate-2 (IRS-2) protein is pivotal in mediating the insulin/IGF signaling pathway in β-cells. In fact, IRS-2 is critically required for β-cell compensation in conditions of increased insulin demand and for β-cell survival. Tungstate is a powerful antidiabetic agent that has been shown to promote β-cell recovery in toxininduced diabetic rodent models. In this study, we investigated whether tungstate could prevent the onset of diabetes in a scenario of dysregulated insulin/IGF signaling and massive β-cell death. To this end, we treated mice deficient in IRS2 (Irs2-/-), which exhibit severe β-cell loss, with tungstate for 3 wk. Tungstate normalized glucose tolerance in Irs2-/- mice in correlation with increased β-cell mass, increased β-cell replication, and a striking threefold reduction in β-cell apoptosis. Islets from treated Irs2-/- exhibited increased phosphorylated Erk1/2. Interestingly, tungstate repressed apoptosis-related genes in Irs2-/- islets in vitro, and ERK1/2 blockade abolished some of these effects. Gene expression profiling showed evidence of a broad impact of tungstate on cell death pathways in islets from Irs2-/- mice, consistent with reduced apoptotic rates. Our results support the finding that β-cell death can be arrested in the absence of IRS2 and that therapies aimed at reversing β-cell mass decline are potential strategies to prevent the progression to T2D. © 2014 the American Physiological Society.

Loading Research Center Biomedica En Red Of Diabetes fermedades Metabolicas Asoc collaborators
Loading Research Center Biomedica En Red Of Diabetes fermedades Metabolicas Asoc collaborators